Skip to content

Efficacy of allergen immunotheary in preoperative and postoperative allergic rhinitis with adenoid hypertrophy in children

Efficacy of allergen immunotheary in preoperative and postoperative allergic rhinitis with adenoid hypertrophy in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063899
Enrollment
Unknown
Registered
2022-09-20
Start date
2022-09-20
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis with adenoid hypertrophy

Interventions

Nonsurgical + desensitization:desensitization
Non-surgical + non-desensitization:symptomatic treatment
surgical + desensitization:surgical + desensitization
surgical + non-desensitization:surgery

Sponsors

Department of of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diagnosis of allergic rhinitis was in line with the guidelines for diagnosis and treatment of pediatric rhinitis, adenoid hypertrophy was diagnosed by endoscopy or cranial lateral radiography, allergen was dust mite, age 5-14 years old, allergic rhinitis history was more than 1 year, the children and their guardians agreed to participate in the study and cooperate with the treatment, and signed the informed consent

Exclusion criteria

Exclusion criteria: Not give priority to with dust mites allergic or allergic to dust mites allergic source there is severe, hypodermic desensitization treatment interruption, has a history of sublingual desensitization, merger of nasopharyngeal abnormal anatomical structure, serious or uncontrolled asthma, associated with other autoimmune diseases, with the other organ systems diseases, allergic to institute with drugs or do not accept the above treatment

Design outcomes

Primary

MeasureTime frame
lateral cephalometric X ray film;OSA-18 Sleep questionnaire;

Secondary

MeasureTime frame
ECP and MPO tests of nasal secretions;PRQLQ;VAS;

Countries

China

Contacts

Public ContactZe-Zhang Tao
taozezhang@163.com13907141892

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026